Effects of SeprafilmU (sodium hyaluranate-based bioresorbable), SepracoatU (0.4% hyaluronic acid), and Ringer's lactate on the prevention of postsurgical adhesion formation in rat models

By Ustun C.   I. I. Kocak    

Journal of Obstetrics & Gynaecology, Vol. 20, Iss. 1, 2000-01 ,pp. : 78-80

Informa Healthcare

Access to resources Recommend Favorite

Gonadotropin-releasing hormone agonist therapy induces apoptosis in uterine leiomyoma

By Higashijima T.   Kataoka A.   Nishida T.   Yakushiji M.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 68, Iss. 1, 1996-09 ,pp. : 169-173

Elsevier

Access to resources Recommend Favorite

Use of intraperitoneal interferon -2b therapy after conservative surgery for endometriosis and postoperative medical treatment with depot gonadotropin-releasing hormone analog: a randomized clinical trial

By Acien P.   Quereda F.   Campos A.   Gomez-Torres M.-J.   Velasco I.   Gutierrez M.  

Fertility and Sterility, Vol. 78, Iss. 4, 2002-10 ,pp. : 705-711

Elsevier

Access to resources Recommend Favorite

Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome

By Kol S.  

Fertility and Sterility, Vol. 81, Iss. 1, 2004-01 ,pp. : 1-5

Elsevier

Access to resources Recommend Favorite

Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis

By Surrey E.S.   Silverberg K.M.   Surrey M.W.   Schoolcraft W.B.  

Fertility and Sterility, Vol. 78, Iss. 4, 2002-10 ,pp. : 699-704

Elsevier

Access to resources Recommend Favorite